Cross-protection provided by live Shigella mutants lacking major antigens

International Journal of Medical Microbiology

Volumn 303, Issue 4, 2013, Pages 167-175

  Szijártó, Valéria ^a   Hunyadi Gulyás, Éva ^b   Emody, Levente ^a   Pál, Tibor ^c   Nagy, Gábor ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cross protection; Immune response; Invasion plasmid; Live vaccine; LPS; Shigella

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BIFUNCTIONAL ACETALDEHYDE COA ALCOHOL DEHYDROGENASE; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; ELONGATION FACTOR TU; FORMATE ACETYLTRANSFERASE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCINE DEHYDROGENASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INITIATION FACTOR 2; IPA ANTIGEN; O ANTIGEN; OUTER MEMBRANE PORIN PROTEIN C; OUTER MEMBRANE PROTEIN A PRECURSOR; OUTER MEMBRANE PROTEIN ASSEMBLY COMPLEX SUBUNIT YFGL; PHOSPHATE ACETYLTRANSFERASE; PREPROTEIN TRANSLOCASE SUBUNIT SECA; PUTATIVE OUTER MEMBRANE PORIN PROTEIN C PRECURSOR; PYRUVATE DEHYDROGENASE SUBUNIT E1; SHIGELLA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; CROSS PROTECTION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MOUSE; NONHUMAN; SEROTYPE; SHIGELLA; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; CROSS PROTECTION; DISEASE MODELS, ANIMAL; DYSENTERY, BACILLARY; FEMALE; GENE DELETION; MICE; MICE, INBRED BALB C; MUTATION; SHIGELLA; SHIGELLA VACCINES; VACCINES, ATTENUATED;

EID: 84877106302     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.02.017     Document Type: Article

References (42)

1. Bingrui W. Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials. Arch. Roum. Pathol. Exp. Microbiol. 1984, 43:285-289.
2. Cam P.D., Pal T., Lindberg A.A. Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients. J. Clin. Microbiol. 1993, 31:454-457.
3. Carneiro C.R., Postol E., Nomizo R., Reis L.F., Brentani R.R. Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureus. Microbes Infect. 2004, 6:604-608.
4. Cersini A., Salvia A.M., Bernardini M.L. Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect. Immun. 1998, 66:549-557.
5. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6640-6645.
6. Formal S.B., Oaks E.V., Olsen R.E., Wingfield-Eggleston M., Snoy P.J., Cogan J.P. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J. Infect. Dis. 1991, 164:533-537.
7. Henriksen A.Z., Maeland J.A. Serum antibodies to outer membrane proteins of Escherichia coli in healthy persons and patients with bacteremia. J. Clin. Microbiol. 1987, 25:2181-2188.
8. Hoare A., Bravo D., Martinic M., Valvano M.A., Contreras I., Alvarez S.A. The normal chain length distribution of the O antigen is required for the interaction of Shigella flexneri 2a with polarized Caco-2 cells. Biol. Res. 2012, 45:21-26.
9. Hong M., Payne S.M. Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol. Microbiol. 1997, 24:779-791.
10. Hughes M.J., Moore J.C., Lane J.D., Wilson R., Pribul P.K., Younes Z.N., Dobson R.J., Everest P., Reason A.J., Redfern J.M., Greer F.M., Paxton T., Panico M., Morris H.R., Feldman R.G., Santangelo J.D. Identification of major outer surface proteins of Streptococcus agalactiae. Infect. Immun. 2002, 70:1254-1259.
11. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., Adak G.K., Levine M.M. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 1999, 77:651-666.
12. Kurupati P., Ramachandran N.P., Poh C.L. Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice. Clin. Vaccine Immunol. 2011, 18:82-88.
13. Law B.J., Marks M.I. Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA. J. Infect. Dis. 1985, 151:988-994.
14. Le-Barillec K., Magalhaes J.G., Corcuff E., Thuizat A., Sansonetti P.J., Phalipon A., Di Santo J.P. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol. 2005, 175:1735-1740.
15. Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., Sztein M.B. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat. Rev. Microbiol. 2007, 5:540-553.
16. Li A., Pal T., Forsum U., Lindberg A.A. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers. Vaccine 1992, 10:395-404.
17. Lindberg A.A., Karnell A., Stocker B.A., Katakura S., Sweiha H., Reinholt F.P. Development of an auxotrophic oral live Shigella flexneri vaccine. Vaccine 1988, 6:146-150.
18. Lindberg A.A., Pal T. Strategies for development of potential candidate Shigella vaccines. Vaccine 1993, 11:168-179.
19. Maurelli A.T., Blackmon B., Curtiss R. Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid. Infect. Immun. 1984, 43:397-401.
20. Meitert T., Ciudin L., Pencu E., Tonciu M., Gheorghe G. Efficiency of immunoprophylaxis and immunotherapy by live dysentery vaccine administration in children and adults collectivities. Arch. Roum. Pathol. Exp. Microbiol. 1982, 41:357-369.
21. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7:145-173.
22. Nagy G., Emody L., Pal T. Strategies for the development of vaccines conferring broad-spectrum protection. Int. J. Med. Microbiol. 2008, 298:379-395.
23. Nagy G., Palkovics T., Otto A., Kusch H., Kocsis B., Dobrindt U., Engelmann S., Hecker M., Emody L., Pal T., Hacker J. "Gently rough": the vaccine potential of a Salmonella enterica regulatory lipopolysaccharide mutant. J. Infect. Dis. 2008, 198:1699-1706.
24. Nataro J.M. Global Burden of Acute Diarrhoeal Disease. SGM Autumn Conference 2011, Abstract book, p. 10.
25. Noriega F.R., Liao F.M., Maneval D.R., Ren S., Formal S.B., Levine M.M. Strategy for cross-protection among Shigella flexneri serotypes. Infect. Immun. 1999, 67:782-788.
26. Oaks E.V., Hale T.L., Formal S.B. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect. Immun. 1986, 53:57-63.
27. Pashine A., John B., Rath S., George A., Bal V. Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence. Int. Immunol. 1999, 11:481-489.
28. Phalipon A., Kaufmann M., Michetti P., Cavaillon J.M., Huerre M., Sansonetti P., Kraehenbuhl J.P. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J. Exp. Med. 1995, 182:769-778.
29. Phalipon A., Mulard L.A., Sansonetti P.J. Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?. Microbes Infect. 2008, 10:1057-1062.
30. Picking W.L., Nishioka H., Hearn P.D., Baxter M.A., Harrington A.T., Blocker A., Picking W.D. IpaD of Shigella flexneri is independently required for regulation of Ipa protein secretion and efficient insertion of IpaB and IpaC into host membranes. Infect. Immun. 2005, 73:1432-1440.
31. Pore D., Mahata N., Pal A., Chakrabarti M.K. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One 2011, 6:e22663-e22670.
32. Prymula R., Schuerman L. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix. Expert Rev. Vaccines 2009, 8:1479-1500.
33. Ranallo R.T., Kaminski R.W., George T., Kordis A.A., Chen Q., Szabo K., Venkatesan M.M. Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants. Infect. Immun. 2010, 78:400-412.
34. Reed L.J., Muench H. A simple method of estimating fifty percent end points. Am. J. Hyg. 1938, 493-497.
35. Roche A.M., King S.J., Weiser J.N. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 2007, 75:2469-2475.
36. Russo T.A., Beanan J.M., Olson R., Genagon S.A., MacDonald U., Cope J.J., Davidson B.A., Johnston B., Johnson J.R. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine 2007, 25:3859-3870.
37. Schroeder G.N., Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin. Microbiol. Rev. 2008, 21:134-156.
38. Thatte J., Rath S., Bal V. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response. Int. Immunol. 1993, 5:1431-1436.
39. van de Verg L.L., Mallett C.P., Collins H.H., Larsen T., Hammack C., Hale T.L. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect. Immun. 1995, 63:1947-1954.
40. Venkatesan M., Fernandez-Prada C., Buysse J.M., Formal S.B., Hale T.L. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain. Vaccine 1991, 9:358-363.
41. Wei J., Goldberg M.B., Burland V., Venkatesan M.M., Deng W., Fournier G., Mayhew G.F., Plunkett G., Rose D.J., Darling A., Mau B., Perna N.T., Payne S.M., Runyen-Janecky L.J., Zhou S., Schwartz D.C., Blattner F.R. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect. Immun. 2003, 71:2775-2786.
42. Yavzori M., Cohen D., Wasserlauf R., Ambar R., Rechavi G., Ashkenazi S. Identification of Shigella species in stool specimens by DNA amplification of different loci of the Shigella virulence plasmid. Eur. J. Clin. Microbiol. Infect. Dis. 1994, 13:232-237.